Back
Speaker illustration

Doctor Ji Fang He

Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing (China)

Member of:

European Society of Cardiology

Bachelor of Clinical Medicine, Capital Medical University，Beijing, China. M.S. in Medicine, University of Queensland, Australia. Currently working at Chaoyang Hospital Heart Center of Capital Medical University, as the coronary interventional cardiologist. Clinical work and research scope includes complex coronary lesions, re-perfusion damage during intervention, treatment of no reflow phenomenon, contrast agent nephropathy prevention and treatment, etc.

Presentations

A pilot randomized controlled trial of novel reperfusion method in patients of acute st elevation myocardial infarction during primary percutaneous coronary intervention

Event: ESC Congress 2023

Topic: Primary Percutaneous Coronary Intervention (PCI)

Session: Complex patients and lesions

Access
Like
Thumbnail

LGE-cMRI assessment of volume controlled reperfusion method in primary percutaneous coronary intervention in patients with ST elevated myocardial infarction

Event: ESC Congress 2021 - The Digital Experience

Topic: Percutaneous Coronary Intervention (PCI)

Session: Interventional Cardiology ePosters

Access
Like
Thumbnail

Combined modified balloons and Saito's modified JBT for calcified coronary birucation lesions

Event: ESC Congress 2019

Topic: Technique

Session: High risk percutaneous coronary intervention: STEMI, CTO, atherectomy bifurcations shock

Access
Like
Thumbnail

An effective manipulation method with ebu guiding catheter for left coronary artery engagement under severe subclavian arterial tortuousity during trans-radial approach

Event: ESC Congress 2018

Topic: Technique

Session: Coronary interventions : technique

Access
Like
Thumbnail

Short term benzbromarone treatment in patients with chronic kidney disease accompanied with hyperuricemia undergoing elective coronary intervention a prospective study

Event: ESC Congress 2017

Topic: PCI: procedural complications

Session: PCI - Adjunctive drug therapy

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources